{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:32:42Z","timestamp":1747222362755,"version":"3.40.5"},"reference-count":0,"publisher":"Sociedad Espanola de Quimioterapia","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Esp Quimioter"],"published-print":{"date-parts":[[2023,11,27]]},"DOI":"10.37201\/req\/055.2023","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:47:33Z","timestamp":1697003253000},"page":"645-647","source":"Crossref","is-referenced-by-count":0,"title":["Defining new therapeutic scenarios for oritavancin: severe bacteremic Staphylococcus aureus skin and soft tissue infection in a severely immunocompromised oncology patient"],"prefix":"10.37201","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7502-2946","authenticated-orcid":false,"given":"Javier","family":"Moreno Izarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1080-3128","authenticated-orcid":false,"given":"Anne","family":"Brunst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1545-4542","authenticated-orcid":false,"given":"Jose Antonio","family":"Carmona \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4750-6485","authenticated-orcid":false,"given":"Francisco","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2607-1025","authenticated-orcid":false,"given":"Juan Manuel","family":"M\u00e1rtir Alario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"23328","published-online":{"date-parts":[[2023,10,11]]},"container-title":["Revista Espa\u00f1ola de Quimioterapia"],"original-title":["Definiendo nuevos escenarios terap\u00e9uticos para oritavancina: severa infecci\u00f3n bacteri\u00e9mica de piel y partes blandas por Staphylococcus aureus en una paciente oncol\u00f3gica intensamente inmunodeprimida"],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T09:35:23Z","timestamp":1701336923000},"score":1,"resource":{"primary":{"URL":"https:\/\/seq.es\/abstract\/rev-esp-quimioter-2023-october-11\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11,27]]},"published-print":{"date-parts":[[2023,11,27]]}},"URL":"https:\/\/doi.org\/10.37201\/req\/055.2023","relation":{},"ISSN":["0214-3429","1988-9518"],"issn-type":[{"type":"print","value":"0214-3429"},{"type":"electronic","value":"1988-9518"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}